Zack Investment Research has lowered ZEALAND PHARMA’S shares to hold

Zack Investment Research has lowered ZEALAND PHARMA / S (NASDAQ: ZEAL) shares from a purchase rating to a hold rating in a research note issued to investors on Friday, reports Zacks.com.

"Zealand Pharma A / S is a biotechnology company," according to Zacks. This focused on identifying, designing and improving peptide-based drugs.

Located in Copenhagen, Denmark, Zealand Pharma A / S. "Many other equity analyst....